XDx and LabCorp Enter Into Collaboration and License Agreement to Develop Lupus Flare Predictor Test.
In: Biomedical Market Newsletter, Jg. 21 (2012-05-25), S. 1-2
serialPeriodical
Zugriff:
The article informs that XDx Inc. has signed a license agreement with Laboratory Corp. of America Holdings for the systemic lupus erythematosus (SLE) diagnostic test. It mentions that SLE, an autoimmune disease is currently being treated with the help of combination therapy. It further informs that the AlloMap technology of Xdx helps in determining the probability of cellular rejection for post-cardiac transplant patient.
Titel: |
XDx and LabCorp Enter Into Collaboration and License Agreement to Develop Lupus Flare Predictor Test.
|
---|---|
Zeitschrift: | Biomedical Market Newsletter, Jg. 21 (2012-05-25), S. 1-2 |
Veröffentlichung: | 2012 |
Medientyp: | serialPeriodical |
ISSN: | 1064-4180 (print) |
Schlagwort: |
|
Sonstiges: |
|